Live donor liver transplantation for alcoholic hepatitis.

Abstract:

:Liver transplantation is a definitive therapy for patients with end-stage liver disease and cirrhosis, with improvement in survival and quality of life. Patients are carefully screened and selected for this modality of treatment to achieve maximum survival benefit. For example, a patient with hepatocellular carcinoma is a candidate if he or she is within Milan criteria and has no significant comorbidity. Similarly, patients with alcoholic cirrhosis are transplant candidates if they are deemed to have been rehabilitated from abusive alcohol consumption and are at low risk for recidivism. More recently, carefully selected patients with alcoholic hepatitis have been successfully transplanted. The preferred transplantation modality is cadaveric liver transplantation. However, living donor liver transplantation is carried out if there is no cadaveric liver organ allocation system, or if the patient is deemed to be at low priority for cadaveric organ transplantation based on the allocation system. Living donor liver transplantation for alcoholic hepatitis needs to be addressed with this background in mind.

journal_name

Hepatol Int

journal_title

Hepatology international

authors

Singal AK,Kamath PS

doi

10.1007/s12072-016-9770-1

subject

Has Abstract

pub_date

2017-01-01 00:00:00

pages

34-37

issue

1

eissn

1936-0533

issn

1936-0541

pii

10.1007/s12072-016-9770-1

journal_volume

11

pub_type

杂志文章
  • Current status and perspectives for computer-aided ultrasonic diagnosis of liver lesions using deep learning technology.

    abstract::An ultrasound (US) examination is a common noninvasive technique widely applied for diagnosis of a variety of diseases. Based on the rapid development of US equipment, many US images have been accumulated and are now available and ready for the preparation of a database for the development of computer-aided US diagnos...

    journal_title:Hepatology international

    pub_type: 杂志文章,评审

    doi:10.1007/s12072-019-09937-4

    authors: Nishida N,Yamakawa M,Shiina T,Kudo M

    更新日期:2019-07-01 00:00:00

  • Pharmacologic prevention of variceal bleeding and rebleeding.

    abstract:BACKGROUND:Variceal bleeding is a major complication of portal hypertension, which is associated with significant mortality. Moreover, patients surviving a variceal bleeding episode have very high risk of rebleeding, which is associated with mortality as high as that of the first bleed. Because of this, prevention of b...

    journal_title:Hepatology international

    pub_type: 杂志文章,评审

    doi:10.1007/s12072-017-9833-y

    authors: Baiges A,Hernández-Gea V,Bosch J

    更新日期:2018-02-01 00:00:00

  • Complications constitute a major risk factor for mortality in hepatitis B virus-related acute-on-chronic liver failure patients: a multi-national study from the Asia-Pacific region.

    abstract:BACKGROUND AND AIM:Cirrhosis is a controversial determinant of mortality in HBV-related acute-on-chronic liver failure (HBV-ACLF). The present study aimed to explore the effects of cirrhosis and the associated risk factors, especially its complications, on the outcome of HBV-ACLF. METHODS:A prospective-retrospective c...

    journal_title:Hepatology international

    pub_type: 杂志文章

    doi:10.1007/s12072-019-09992-x

    authors: Chen T,Yang Z,Choudhury AK,Al Mahtab M,Li J,Chen Y,Tan SS,Han T,Hu J,Hamid SS,Huei LG,Ghazinian H,Nan Y,Chawla YK,Yuen MF,Devarbhavi H,Shukla A,Abbas Z,Sahu M,Dokmeci AK,Lesmana LA,Lesmana CRA,Xin S,Duan Z,

    更新日期:2019-11-01 00:00:00

  • Anti-viral therapy in hepatitis B virus reactivation with acute-on-chronic liver failure.

    abstract::Hepatitis B virus (HBV) reactivation with hepatic decompensation leading to acute on chronic liver failure is not uncommon. It is associated with high mortality of up to 30-70%. Prognostic factors for mortality include high bilirubin level, more prolonged prothrombin time, low platelet count and presence of pre-existi...

    journal_title:Hepatology international

    pub_type: 杂志文章,评审

    doi:10.1007/s12072-014-9569-x

    authors: Yuen MF

    更新日期:2015-07-01 00:00:00

  • Efficacy and resistance of entecavir following 3 years of treatment of Japanese patients with lamivudine-refractory chronic hepatitis B.

    abstract:PURPOSE:Lamivudine treatment of chronic hepatitis B (CHB) is associated with frequent resistance and loss of clinical benefit. We present outcomes of lamivudine-refractory Japanese patients treated with entecavir for 3 years. METHODS:Eighty-two patients refractory to lamivudine therapy received entecavir 0.5 or 1 mg d...

    journal_title:Hepatology international

    pub_type: 杂志文章

    doi:10.1007/s12072-009-9162-x

    authors: Karino Y,Toyota J,Kumada H,Katano Y,Izumi N,Kobashi H,Sata M,Moriyama M,Imazeki F,Kage M,Ishikawa H,Masaki N,Seriu T,Omata M

    更新日期:2010-02-06 00:00:00

  • Sofosbuvir-velpatasvir plus ribavirin in Japanese patients with genotype 1 or 2 hepatitis C who failed direct-acting antivirals.

    abstract:BACKGROUND/PURPOSE:In Japan, there is a growing population of patients with chronic hepatitis C virus (HCV) infection who failed a direct-acting antiviral (DAA)-based regimen. In this Phase 3 study, we evaluated sofosbuvir-velpatasvir plus ribavirin in Japanese patients with genotype 1 or 2 HCV infection who previously...

    journal_title:Hepatology international

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1007/s12072-018-9878-6

    authors: Izumi N,Takehara T,Chayama K,Yatsuhashi H,Takaguchi K,Ide T,Kurosaki M,Ueno Y,Toyoda H,Kakizaki S,Tanaka Y,Kawakami Y,Enomoto H,Ikeda F,Jiang D,De-Oertel S,McNabb BL,Camus G,Stamm LM,Brainard DM,McHutchison JG,M

    更新日期:2018-07-01 00:00:00

  • The therapeutic response of antiviral therapy in HBsAg-positive renal transplant recipients and a long-term follow-up.

    abstract:BACKGROUND:Early prediction of lamivudine (LAM) response by individualized monitoring of serum HBV DNA like roadmap concept, and investigation of the outcome after LAM discontinuation in renal transplant recipients (RTRs) with chronic hepatitis B (CHB). METHODS:We conducted a study on 19 RTRs with HBV infection receiv...

    journal_title:Hepatology international

    pub_type: 杂志文章

    doi:10.1007/s12072-011-9295-6

    authors: Hu TH,Tsai MC,Chen YT,Chien YS,Hung CH,Chen TC,Tseng PL,Chang KC,Yen YH

    更新日期:2012-04-01 00:00:00

  • The utility of noninvasive scores in assessing the prevalence of nonalcoholic fatty liver disease and advanced fibrosis in type 1 diabetic patients.

    abstract:GOALS:The aim of our study is to assess the prevalence of nonalcoholic fatty liver disease (NAFLD) and advanced hepatic fibrosis in patients with type 1 diabetes (T1D) using simple noninvasive scores. BACKGROUND:There is paucity of data on the prevalence of NAFLD in T1D. Moreover, T1D could be a risk factor for advanc...

    journal_title:Hepatology international

    pub_type: 杂志文章

    doi:10.1007/s12072-017-9840-z

    authors: Singh A,Le P,Lopez R,Alkhouri N

    更新日期:2018-01-01 00:00:00

  • Incidence and risk factors for surveillance failure in patients with regular hepatocellular carcinoma surveillance.

    abstract:BACKGROUND:Initial presentation of hepatocellular carcinoma (HCC) at an advanced stage in patients under a regular surveillance program is a devastating problem. AIMS:We assessed the prevalence and factors associated with this surveillance failure. METHODS:A total of 304 HCC patients who received regular surveillance...

    journal_title:Hepatology international

    pub_type: 杂志文章

    doi:10.1007/s12072-013-9462-z

    authors: Sinn DH,Yi J,Choi MS,Choi D,Gwak GY,Paik YH,Lee JH,Koh KC,Paik SW,Yoo BC

    更新日期:2013-10-01 00:00:00

  • Vitamin A levels reflect disease severity and portal hypertension in patients with cirrhosis.

    abstract:BACKGROUND AND AIMS:The liver plays a key role in the storage, metabolism and homeostasis of fat-soluble vitamins. We investigated the relation of Vitamin(Vit)A/D/E serum levels with severity of liver disease and portal hypertension (PHT). METHODS:VitA/D/E serum levels were assessed in 234 patients with advanced chron...

    journal_title:Hepatology international

    pub_type: 杂志文章

    doi:10.1007/s12072-020-10112-3

    authors: Simbrunner B,Semmler G,Stadlmann A,Scheiner B,Schwabl P,Paternostro R,Bucsics T,Bauer D,Eigenbauer E,Pinter M,Stättermayer AF,Quehenberger P,Marculescu R,Trauner M,Mandorfer M,Reiberger T

    更新日期:2020-12-01 00:00:00

  • Acute kidney injury in hepatitis B-related acute-on-chronic liver failure without preexisting liver cirrhosis.

    abstract:BACKGROUND AND AIM:Acute kidney injury (AKI), as defined by the Acute Kidney Injury Network, has been widely investigated in decompensated liver cirrhosis patients. AKI is frequently progressive and independently associated with mortality in these patients. However, in the Asia-Pacific region, the majority of cases of ...

    journal_title:Hepatology international

    pub_type: 杂志文章

    doi:10.1007/s12072-015-9636-y

    authors: Huang Z,Lin C,Fang J,Wang N,Zhou R,Pan C

    更新日期:2015-07-01 00:00:00

  • End-stage liver disease patients with MELD >40 have higher waitlist mortality compared to Status 1A patients.

    abstract:BACKGROUND AND AIMS:Status 1A patients are prioritized over end-stage liver disease (ESLD) for liver transplantation (LT). ESLD patients with high MELD may have higher waitlist mortality than Status 1A patients, and may require LT more urgently. METHODS:Using United Network for Organ Sharing registry data, we retrospe...

    journal_title:Hepatology international

    pub_type: 杂志文章

    doi:10.1007/s12072-016-9735-4

    authors: Ahn J,Bhuket T,Mosadeghi S,Frenette C,Liu B,Wong RJ

    更新日期:2016-09-01 00:00:00

  • Thy1-positive bone marrow stem cells express liver-specific genes in vitro and can mature into hepatocytes in vivo.

    abstract::The bone marrow contains stem cells that have the potential to differentiate into a variety of organ-specific mature cells, including the liver and the pancreas. Recently, the origin of hepatic progenitors and hepatocytes was identified to be the bone marrow. However, evidence that describes which cells, among all bon...

    journal_title:Hepatology international

    pub_type: 杂志文章

    doi:10.1007/s12072-007-9031-4

    authors: Bae SH,Choi JY,Yoon SK,Oh IH,Yoon KH,Park ST,Kim GD,Oh SH,Petersen BE

    更新日期:2008-03-01 00:00:00

  • Chinese guidelines on the management of ascites and its related complications in cirrhosis.

    abstract::The Chinese Society of Hepatology developed the current guidelines for the Management of Ascites and Its Related Complications in Cirrhosis based on the published evidences and the panelists' consensus. The guidelines provided recommendations for the diagnosis and management of cirrhotic ascites emphasizing a step-wis...

    journal_title:Hepatology international

    pub_type: 社论,实务指引

    doi:10.1007/s12072-018-09923-2

    authors: Chinese Society of Hepatology, Chinese Medical Association.,Xu X,Duan Z,Ding H,Li W,Jia J,Wei L,Linghu E,Zhuang H

    更新日期:2019-01-01 00:00:00

  • Hepatitis B reactivation after chemotherapy: two decades of clinical research.

    abstract::Hepatitis due to hepatitis B virus reactivation after cytotoxic or immunosuppressive therapy is a serious cause of liver-related morbidity and mortality. With the characterization of the underlying pathogenesis, much progress in the management of this important clinical problem has been made in the past 2 decades. By ...

    journal_title:Hepatology international

    pub_type: 杂志文章

    doi:10.1007/s12072-008-9056-3

    authors: Lau GK

    更新日期:2008-06-01 00:00:00

  • Spontaneous bacterial peritonitis from Salmonella: an unusual bacterium with unusual presentation.

    abstract::Spontaneous bacterial peritonitis (SBP) is a common cause of morbidity and mortality in patients with advanced cirrhosis and portal hypertension. While gram-negative rods and Enterococcus species are the common offending organisms, Salmonella has also been recognized as a rare and atypical offending organism. Atypical...

    journal_title:Hepatology international

    pub_type: 杂志文章

    doi:10.1007/s12072-008-9087-9

    authors: Rajekar H,Wai CT,Lee KH,Wong SY,Tan KC

    更新日期:2008-09-01 00:00:00

  • CSH guidelines for the diagnosis and treatment of drug-induced liver injury.

    abstract::Drug-induced liver injury (DILI) is an important clinical problem, which has received more attention in recent decades. It can be induced by small chemical molecules, biological agents, traditional Chinese medicines (TCM), natural medicines (NM), health products (HP), and dietary supplements (DS). Idiosyncratic DILI i...

    journal_title:Hepatology international

    pub_type: 社论

    doi:10.1007/s12072-017-9793-2

    authors: Yu YC,Mao YM,Chen CW,Chen JJ,Chen J,Cong WM,Ding Y,Duan ZP,Fu QC,Guo XY,Hu P,Hu XQ,Jia JD,Lai RT,Li DL,Liu YX,Lu LG,Ma SW,Ma X,Nan YM,Ren H,Shen T,Wang H,Wang JY,Wang TL,Wang XJ,Wei L,Xie Q,Xie W,

    更新日期:2017-05-01 00:00:00

  • Ultrasound surveillance for early detection of hepatocellular carcinoma among patients with chronic hepatitis C.

    abstract:BACKGROUND AND AIMS:Ultrasonography is the most frequently used modality in surveillance for HCC among patients with chronic hepatitis C. However, the optimal surveillance interval is still controversial and the usefulness of supplementary tumor marker determination has not been confirmed. METHODS:A total of 243 cases...

    journal_title:Hepatology international

    pub_type: 杂志文章

    doi:10.1007/s12072-009-9145-y

    authors: Sato T,Tateishi R,Yoshida H,Ohki T,Masuzaki R,Imamura J,Goto T,Kanai F,Obi S,Kato N,Shiina S,Kawabe T,Omata M

    更新日期:2009-12-01 00:00:00

  • Effect of hepatitis B surface antibody in patients with core antibody-positive liver transplantation: a systematic review and meta-analysis.

    abstract:BACKGROUND AND AIM:There is an increased awareness of de novo hepatitis B virus (HBV) infection (DNH) in hepatitis B surface antigen (HBsAg)-negative recipients receiving hepatitis B core antibody (HBcAb)-positive liver organ. Whether hepatitis B surface antibody (HBsAb) has positive result on preventing the occurrence...

    journal_title:Hepatology international

    pub_type: 杂志文章,meta分析

    doi:10.1007/s12072-020-10021-5

    authors: Yang Y,Huang A,Zhao Y

    更新日期:2020-03-01 00:00:00

  • Treatment of chronic hepatitis C genotype 3 with Sofosbuvir-based therpy: a real-life study.

    abstract:BACKGROUND AND AIMS:Recently, Sofosbuvir was launched in India at affordable cost. We conducted a real-life study to determine the efficacy and safety of Sofosbuvir plus Ribavirin, with and without peginterferon-alfa 2a, in patients with chronic hepatitis C (CHC) genotype 3, the commonest genotype in South Asia. METHO...

    journal_title:Hepatology international

    pub_type: 杂志文章

    doi:10.1007/s12072-017-9794-1

    authors: Sidhu SS,Malhi NS,Goyal O,Singh R,Dutta U,Grover R,Sidhu JS,Nanda V,Saluja H,Bansal A,Singh G,Sehgal A,Kishore H,Sidhu S

    更新日期:2017-05-01 00:00:00

  • Dynamic changes of T cell receptor repertoires in patients with hepatitis B virus-related acute-on-chronic liver failure.

    abstract:BACKGROUND AND AIMS:T cell-mediated immune injury plays a critical role in the pathogenesis of hepatitis B virus-related acute-on-chronic liver failure (HBV-ACLF). Given the high short-term mortality and crucial role of T cells in the disease progression, it is necessary to investigate the dynamics of T cell clones dur...

    journal_title:Hepatology international

    pub_type: 杂志文章

    doi:10.1007/s12072-019-10008-x

    authors: Shen G,Sun S,Huang J,Deng H,Xu Y,Wang Z,Tang X,Gong X

    更新日期:2020-01-01 00:00:00

  • Hepatitis B virus reactivation in patients receiving cancer chemotherapy: natural history, pathogenesis, and management.

    abstract::Chronic hepatitis B virus (HBV) infection is endemic in the Asian-Pacific region, and reactivation of HBV post-cancer chemotherapy has become an emerging clinical challenge. Patients with detectable serum HBV DNA before chemotherapy and those receiving intensive chemotherapy are particularly at a risk of HBV reactivat...

    journal_title:Hepatology international

    pub_type: 杂志文章

    doi:10.1007/s12072-011-9279-6

    authors: Liu CJ,Chen PJ,Chen DS,Kao JH

    更新日期:2013-06-01 00:00:00

  • A case-control study on sequence variations in the enhancer II/core promoter/precore and X genes of hepatitis B virus in patients with hepatocellular carcinoma.

    abstract:PURPOSE:To evaluate the sequence variations in the enhancer II (EnhII)/basal core promotor (BCP)/precore (PC) and X genes of hepatitis B virus (HBV) in Thai patients with hepatocellular carcinoma (HCC) by conducting a cross-sectional case-control study. METHODS:As much as 60 patients with HCC and 60 patients without H...

    journal_title:Hepatology international

    pub_type: 杂志文章

    doi:10.1007/s12072-010-9197-z

    authors: Tangkijvanich P,Sa-Nguanmoo P,Mahachai V,Theamboonlers A,Poovorawan Y

    更新日期:2010-07-31 00:00:00

  • Procaine inhibits the proliferation and DNA methylation in human hepatoma cells.

    abstract:PURPOSE:Transcriptional silencing of tumor suppressor genes associated with DNA hypermethylation has been known as a hallmark of human cancer. In this study, we revealed that a local anesthetic, procaine (PCA), possessed growth-inhibitory and demethylating effect on human hepatoma cells in vitro and in vivo. METHODS:T...

    journal_title:Hepatology international

    pub_type: 杂志文章

    doi:10.1007/s12072-007-9014-5

    authors: Tada M,Imazeki F,Fukai K,Sakamoto A,Arai M,Mikata R,Tokuhisa T,Yokosuka O

    更新日期:2007-09-01 00:00:00

  • An imbalance between stellate cells and γδT cells contributes to hepatocellular carcinoma aggressiveness and recurrence.

    abstract:PURPOSE:The diagnostic potential of hepatic stellate cells (HSCs) and γδT cells for patients with hepatocellular carcinoma (HCC) and their synergistic contributions to the prognosis of these patients have not yet been investigated. The aim of this study was to elucidate the prognostic value of these cells in HCC. METH...

    journal_title:Hepatology international

    pub_type: 杂志文章

    doi:10.1007/s12072-019-09969-w

    authors: Zhou BY,Gong JH,Cai XY,Wang JX,Luo F,Jiang N,Gong JP,Du CY,Liao R

    更新日期:2019-09-01 00:00:00

  • Epigenetic histone modifications in a clinically relevant rat model of chronic ethanol-binge-mediated liver injury.

    abstract:PURPOSE:Ethanol binge augments liver injury after chronic ethanol consumption in humans, but the mechanism behind the enhanced liver injury by ethanol binge is not known. In this study we used a clinically relevant rat model in which liver injury is amplified by binge after chronic ethanol treatment and investigated th...

    journal_title:Hepatology international

    pub_type: 杂志文章

    doi:10.1007/s12072-014-9546-4

    authors: Aroor AR,Restrepo RJ,Kharbanda KK,Shukla SD

    更新日期:2014-09-01 00:00:00

  • An open-label phase I/II study of tamibarotene in patients with advanced hepatocellular carcinoma.

    abstract:AIM:Tamibarotene is a synthetic retinoid expected to inhibit tumor-cell proliferation and to induce apoptosis by selective interaction with retinoic acid receptor α/β. We conducted an open-label phase I/II study to determine the maximum tolerated dose (MTD) and recommended dose (RD), and to evaluate the pharmacokinetic...

    journal_title:Hepatology international

    pub_type: 杂志文章

    doi:10.1007/s12072-013-9459-7

    authors: Kanai F,Obi S,Fujiyama S,Shiina S,Tamai H,Mochizuki H,Koike Y,Imamura J,Yamaguchi T,Saida I,Yokosuka O,Omata M

    更新日期:2014-01-01 00:00:00

  • Depression, fatigue and neurocognitive deficits in chronic hepatitis C.

    abstract::Patients with chronic hepatitis C virus (HCV) infection experience a range of symptoms including depression, fatigue and neurocognitive deficits, impairing quality of life. Depression, in particular, may be reactive to increased psychosocial stress, and the physical symptoms of advanced HCV or associated comorbidities...

    journal_title:Hepatology international

    pub_type: 杂志文章,评审

    doi:10.1007/s12072-018-9879-5

    authors: Yeoh SW,Holmes ACN,Saling MM,Everall IP,Nicoll AJ

    更新日期:2018-07-01 00:00:00

  • Prednisolone plus S-adenosil-L-methionine in severe alcoholic hepatitis.

    abstract:PURPOSE/BACKGROUND:Severe alcoholic hepatitis (AH) is a life-threatening liver disease with a potential of 30-40 % mortality at 1 month. While steroids remain to be a first line therapy, they provide only about 50 % survival benefit. The aim of the study was to evaluate the efficacy of glucocorticoids plus S-adenosylme...

    journal_title:Hepatology international

    pub_type: 杂志文章,多中心研究

    doi:10.1007/s12072-016-9751-4

    authors: Tkachenko P,Maevskaya M,Pavlov A,Komkova I,Pavlov C,Ivashkin V

    更新日期:2016-11-01 00:00:00

  • Renal function and severity of bright liver. Relationship with insulin resistance, intrarenal resistive index, and glomerular filtration rate.

    abstract:AIMS:Relationships of renal function and liver disease are described in acute and chronic liver failure. The aim of the study is to investigate which relationship, if any, is present between severity of non-alcoholic fatty liver disease (NAFLD), assessed by bright liver score (BLS) versus mild-moderate renal insufficie...

    journal_title:Hepatology international

    pub_type: 杂志文章

    doi:10.1007/s12072-011-9254-2

    authors: Catalano D,Trovato GM,Martines GF,Pirri C,Trovato FM

    更新日期:2011-09-01 00:00:00